China healthcare big data platform gets $30m Series B
Weimai, a Chinese healthcare-focused big data platform that operates on a city-by-city basis, has received $30 million in Series B funding led by Cenova Ventures, Source Code Capital, Vision Plus Capital, and Matrix Partners China.
The company was founded in 2013 and received seed funding from Source Code and two individual investors – Eddie Wu, a co-founder of Alibaba Group who chairs the company’s Ali Health subsidiary, and...
More on Greater China
Latest News
Deal focus: Legend backs Mancando’s offline network
Legend Capital sees Mancando's extensive network of brick-and-mortar outlets as the key to bringing greater supply chain efficiency to the Chinese auto parts industry
Advantage buys Vietnam's Elise Fashion
Advantage Partners has made its first acquisition in Vietnam, buying women’s fashion brand Elise Fashion for an undisclosed amount.
GIC leads $125m round for China cancer diagnostics business
GIC Private has led a RMB850 million ($125.5 million) Series C round for Burning Rock, a Chinese cancer diagnostics start-up that is already working with hospitals on products based on DNA sequencing analysis.
Thailand's Beacon leads $6.5m round for local fintech player
Beacon Venture Capital, the VC unit of Thailand’s Kasikornbank, has led a $6.5 million investment in Jitta, a local financial technology provider and stock analysis platform operator.